A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children

Modesti, 2021 McCrindle, 2017, Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association, Circulation, 135, e927, 10.1161/CIR.0000000000000484 Payne, 2021, Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2, JAMA Netw Open, 4, 10.1001/jamanetworkopen.2021.16420 Dufort, 2020, Multisystem inflammatory syndrome in children in New York state, N Engl J Med, 383, 347, 10.1056/NEJMoa2021756 McMurray, 2020, Multisystem inflammatory syndrome in children (MIS-C), a post-viral myocarditis and systemic vasculitis-a critical review of its pathogenesis and treatment, Front Pediatr, 8, 10.3389/fped.2020.626182 Chang, 2014, Viral infections associated with Kawasaki disease, JFormosan MedAssoc, 113, 148 Kim, 2021, IgA levels are associated with coronary artery lesions in Kawasaki disease, Korean Circ J, 51, 267, 10.4070/kcj.2020.0345 Yeo, 2020, Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2, Med Hypotheses, 144 Grifoni, 2020, Interleukin-6 as prognosticator in patients with COVID-19, J Infect, 81, 452, 10.1016/j.jinf.2020.06.008 CDC, 2020 Alsaied, 2021, Review of cardiac involvement in multisystem inflammatory syndrome in children, Circulation, 143, 78, 10.1161/CIRCULATIONAHA.120.049836 Feldstein, 2021, Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19, JAMA, 325, 1074, 10.1001/jama.2021.2091 Rhim, 2021, Etiological and pathophysiological enigmas of severe coronavirus disease 2019, multisystem inflammatory syndrome in children, and Kawasaki disease, Clin Exp Pediatr Feldstein, 2020, Multisystem inflammatory syndrome in U.S. children and adolescents, N Engl J Med, 383, 334, 10.1056/NEJMoa2021680 Medaglia, 2021, Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature, Ital J Pediatr, 47, 95, 10.1186/s13052-021-01041-4 Godfred-Cato, 2020, COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020, MMWR Morb Mortal Wkly Rep, 69, 1074, 10.15585/mmwr.mm6932e2 Tremoulet, 2011, Evolution of laboratory values in patients with Kawasaki disease, Pediatr Infect Dis J, 30, 1022, 10.1097/INF.0b013e31822d4f56 Henderson, 2021, American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2, Arthritis Rheumatol, 73, e13, 10.1002/art.41616 Tse, 2002, Early treatment with intravenous immunoglobulin in patients with Kawasaki disease, J Pediatr, 140, 450, 10.1067/mpd.2002.122469